- Insider Monkey•5 days agoJapan is Breathing Life into the Stem Cell Space, Astellas Pharma (ALPMF) & Pluristem Therapeutics Inc. (PSTI) Are Benefiting
Japan is the stem cell capital of the world. From the Nobel winning efforts of Shinya Yamanaka in the field of mature to pluripotent stem cell reprogramming, to the STAP scandal and its suicide tarnished fallout, if there’s something to talk about in the sector, chances are it happened first in Japan. Japan’s development of […]
- Reuters•2 months ago
Pharmaceutical companies Genentech and OSI Pharmaceuticals LLC will pay $67 million to resolve allegations they made misleading statements about the effectiveness of lung cancer drug Tarceva, the U.S. Justice Department said on Monday. The claims alleged that between 2006 and 2011, the companies misrepresented the effectiveness of Tarceva to physicians and other healthcare providers to treat certain patients with non-small cell lung cancer, the department said in a statement.
|52wk Range||12.50 - 16.67|
|Day's Range||16.12 - 16.20|
|Avg Vol (3m)||72,252|
As of 10:24 AM EDT. Other OTC Delayed Price. Market open.